Journal of Affective Disorders logo Elsevier logo

Publisher: Elsevier

Related content
Volume 61, Number 1, 1 December 2000

< previous issue | all issues | next issue >

Changes in depression and physical decline in older adults: a longitudinal perspective
pp. 1-12(12)
Authors: Penninx B.W.J.H.; Deeg D.J.H.; van Eijk J.T.M.; Beekman A.T.F.; Guralnik J.M.

Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients
pp. 13-22(10)
Authors: Baldessarini R.J.; Tondo L.; Floris G.; Hennen J.

Failure to detect amphetamine or 1-amino-3-phenlypropane in humans or rats receiving the MAO inhibitor tranylcypromine
pp. 23-29(7)
Authors: Sherry R.L.; Rauw G.; McKenna K.F.; Paetsch P.R.; Coutts R.T.; Baker1 G.B.

Protective effect of pregnancy in women with lithium-responsive bipolar disorder
pp. 31-39(9)
Authors: Grof P.; Robbins W.; Alda M.; Berghoefer A.; Vojtechovsky M.; Nilsson A.; Robertson C.

Human fibroblasts as a relevant model to study signal transduction in affective disorders
pp. 51-58(8)
Authors: Manier D.H.; Shelton R.C.; Ellis T.C.; Peterson C.S.; Eiring A.; Sulser F.

Gender differences in the presentation of depressed outpatients: a comparison of descriptive variables
pp. 59-67(9)
Authors: Carter J.D.; Joyce P.R.; Mulder R.T.; Luty S.E.; McKenzie J.

Further evidence for low serum cholesterol and suicidal behaviour
pp. 69-71(3)
Authors: Sarchiapone M.; Roy A.; Camardese G.; De Risio S.

Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression
pp. 73-79(7)
Authors: Londborg P.D.; Smith W.T.; Glaudin V.; Painter J.R.

The correlates of community functioning in patients with bipolar disorder
pp. 81-85(5)
Authors: Kusznir A.; Cooke R.G.; Young L.T.

Is impaired outcome following a first manic episode due to mood-incongruent psychosis?
pp. 87-94(8)
Authors: Strakowski S.M.; Williams J.R.; Sax K.W.; Fleck D.E.; DelBello M.P.; Bourne M.L.

Obstetric complications in patients with depression - a population-based case-control study
pp. 101-106(6)
Authors: Preti A.; Cardascia L.; Zen T.; Pellizzari P.; Marchetti M.; Favaretto G.; Miotto P.

Diminished perception of ambient light: a symptom of clinical depression?
pp. 113-118(6)
Authors: Friberg T.R.; Borrero G.

A double-blind, placebo-controlled, efficacy, safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the treatment of major depression
pp. 119-126(8)
Authors: Feighner J.P.; Ehrensing R.H.; Kastin A.J.; Leonard B.E.; Sverdlov L.; Nicolau G.; Patel A.; Hlavka J.; Abajian H.; Noble J.F.

Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depression
pp. 127-132(6)
Authors: Izumi T.; Inoue T.; Kitagawa N.; Nishi N.; Shimanaka S.; Takahashi Y.; Kusumi I.; Odagaki Y.; Denda K.; Ohmori T.; Koyama T.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page